Rich nations stand to lose hundreds of billions of dollars in economic output over the next five years if poorer countries do not get equal access to Covid-19 vaccines, a report has said as concerns grow about “vaccine nationalism”.
As the World Health Organization (WHO) seeks to plug funding gaps in its ACT Accelerator programme for global Covid-19 treatments, researchers said their findings showed there was a financial – as well as a moral – case for ensuring equal access.
“Governments are increasingly focusing on investments that can help their own economies to rebound,” said Hassan Damluji, deputy director at the Bill & Melinda Gates Foundation, which commissioned the report by the Eurasia Group research firm.
“The ACT Accelerator is precisely one of those investments. It is both the right thing to do, and an investment that will pay dividends by bringing the global economy back from the brink, benefiting all nations.”
As nations prepare to roll out mass Covid-19 vaccination programmes, with Britain becoming the first to approve a vaccine for use this week, there has been concern that “vaccine nationalism” could see poorer countries left behind.
The WHO says the programme needs $38bn (£28bn) – of which about $28bn is still outstanding – without which lower-income countries will not be able to get prompt access to Covid-19 drugs including vaccines.
Thursday’s report assessed the economic benefits of ensuring swift, equal global access to vaccines to 10 major economies – Canada, France, Germany, Japan, Qatar, South Korea, Sweden, United Arab Emirates, the UK and the US.
It found boosts to the global economy as a result meant they stood to gain at least $153bn in 2020-21, and $466bn by 2025, in an analysis based on IMF World Economic Outlook forecasts of varying vaccination scenarios.
The WHO director general, Tedros Adhanom Ghebreyesus, hailed the report, and said contributing to the ACT Accelerator was “the smart thing for all countries – socially, economically and politically”.
Its findings are in line with an earlier study that found wealthy countries stood to lose $119bn a year through uneven vaccine access, said Andrea Taylor, a researcher at the Duke Global Health Institute’s project tracking Covid-19 data.
“It is in the best interests of wealthy nations to invest in equity and it will cost all of us more if we don’t, both in terms of mortality and GDP,” she told the Thomson Reuters Foundation.